Home
About
Overview
Sharing Data
ORCID
Help
History (4)
Add-on cannabidiol in patients with Dravet syndrome: Results of a long-term open-label extension trial.
AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY COMPREHENSIVE CLINICAL PRACTICE GUIDELINES FOR MEDICAL CARE OF PATIENTS WITH OBESITYEXECUTIVE SUMMARYComplete Guidelines available at https://www.aace.com/publications/guidelines.
Formation of disinfection by-products in indoor swimming pool water: the contribution from filling water natural organic matter and swimmer body fluids.
Metabolite Profiles of Incident Diabetes and Heterogeneity of Treatment Effect in the Diabetes Prevention Program.
See All 4 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Add-on cannabidiol in patients with Dravet syndrome: Results of a long-term open-label extension trial.
Add-on cannabidiol in patients with Dravet syndrome: Results of a long-term open-label extension trial. Epilepsia. 2021 10; 62(10):2505-2517.
View in:
PubMed
subject areas
Anticonvulsants
Cannabidiol
Double-Blind Method
Epilepsies, Myoclonic
Epileptic Syndromes
Humans
Seizures
Treatment Outcome
authors with profiles
Jonathan J. Halford